Beghi Ettore, Leone Maurizio, Solari Alessandra
Centro per l'Epilessia, Università di Milano-Bicocca, Ospedale San Gerardo, Monza, Italy.
Epilepsia. 2005;46 Suppl 11:40-2. doi: 10.1111/j.1528-1167.2005.00407.x.
The mortality after a first epileptic seizure is affected by the source of cases, the intensity of the diagnostic work-up, the type and the presumed etiology of the seizure, the length of follow-up, and the modalities of data collection (retrospective vs. prospective). We review the four studies of this topic.
Four studies have been identified which focused on the mortality of the first unprovoked seizures or the first afebrile (provoked or unprovoked) seizure. These included two population-based surveys, one clinic-based community survey, and a randomized clinical trial on the treatment of the first unprovoked generalized tonic-clonic seizure.
A standardized mortality ratio (SMR) of 2.3 (95% confidence interval, CI 1.5-3.3) for unprovoked first seizures was found in a retrospective cohort study in the population of Rochester, Minnesota. The SMR was higher during the first year after the seizures to progressively decrease thereafter. Acute symptomatic seizures carried the higher risk, followed by remote symptomatic seizures, while idiopathic and cryptogenic seizures carried no risk. The increased SMR found in women and in patients aged 0-19 years enrolled in the randomized trial differs from that seen in other mortality studies in epilepsy (SMR being highest in the youngest age groups) and may be a chance finding.
Mortality is increased in patients with a first unprovoked seizure, particularly during the first year after the seizure. This increased mortality is associated with known etiology of the seizure, and is not present when etiology is unknown.
首次癫痫发作后的死亡率受病例来源、诊断检查的强度、发作类型及推测病因、随访时间长度以及数据收集方式(回顾性与前瞻性)的影响。我们对该主题的四项研究进行综述。
已确定四项研究,其聚焦于首次特发性发作或首次无热(诱发性或特发性)发作的死亡率。这些研究包括两项基于人群的调查、一项基于诊所的社区调查以及一项关于首次特发性全面强直阵挛发作治疗的随机临床试验。
在明尼苏达州罗切斯特市人群的一项回顾性队列研究中,发现首次特发性发作的标准化死亡率(SMR)为2.3(95%置信区间,CI 1.5 - 3.3)。发作后的第一年SMR较高,此后逐渐下降。急性症状性发作风险更高,其次是既往症状性发作,而特发性和隐源性发作无风险。在随机试验中纳入的女性和0 - 19岁患者中发现的SMR升高与癫痫其他死亡率研究中所见不同(SMR在最年轻年龄组中最高),可能是偶然发现。
首次特发性发作患者的死亡率增加,尤其是在发作后的第一年。这种死亡率增加与发作的已知病因相关,病因不明时则不存在。